SYNTHESIS
SYNTHESIS

2-Morpholinoacetic acid (compound G)
To a solution of morpholine (1.74 g, 20 mmol) in THF (15 mL) was added triethylamine (3.3 mL, 24 mmol) and ethyl bromoacetate (2.21 mL, 20 mmol) at 0
• C under N 2 . The reaction mixture was stirred to reach the same temperature for 1 h. The solvent was evaporated in vacuo. The mixture was extracted with DCM and water. The organic layer was dried (Na 2 SO 4 ) and concentrated in vacuo, which was used in the next reaction without further purification. To a solution of ethyl 2-morpholinoacetate (1.6 g, 5.8 mmol) in MeOH (10 mL) was added dropwise Claisen's alkali (1.8 mL) at 0
• C. The reaction mixture was stirred to reach room temperature. After the reaction was completed, the solvent was evaporated in vacuo. ture was diluted with water and washed with DCM. The aqueous layer was concentrated by the freeze dryer to give 1.6 g (65%) of 2-morpholinoacetic acid.
1 H-NMR (400 MHz, DMSO-d 6 )δ 2.80 (t, J = 4.5 Hz, 4H), 3.42 (s, 2H), 3.67 ((t, J = 4.5 Hz, 4H), 5.12 (bs, COOH).
2-(4-(2-Hydroxyethyl)piperazin-1-yl)acetic acid (compound J)
To a solution of 1-(2-hydroxyethyl)piperazine (1.3 g, 10 mmol) in THF (10 mL) was added triethylamine (2.1 mL, 15 mmol) and ethyl bromoacetate (1.1 mL, 10 mmol) at 0
• C under N 2 . The reaction mixture was stirred to reach the same temperature for 1 h. The solvent was evaporated in vacuo. The mixture was extracted with DCM and water. The organic layer was dried (Na 2 SO 4 ) and concentrated in vacuo, which was used in the next reaction without further purification. To a solution of ethyl 2-(4-(2-hydroxyethyl)piperazin-1-yl)acetate (1.25 g, 5.8 mmol) in MeOH (10 mL) was added dropwise Claisen's alkali (1.8 mL) at 0
• C. The reaction mixture was stirred to reach room temperature. After the reaction was completed, the solvent was evaporated in vacuo. The mixture was diluted with water and washed with DCM. The aqueous layer was concentrated by the freeze dryer to give 640 mg (58%) of 2-(4-(2-Hydroxyethyl)piperazin-1-yl)acetic acid.
1 H- NMR (400 MHz, DMSO-d 6 ): δ 2.37 (t, j = 6.24 Hz, 2H), 2.45 (br, 4H), 2.63 (br, 4H), 3.08 (s, 2H), 3.47 (t, J = 6.27 Hz, 2H).
N-Cyclohexylglycine (compound M)
Cyclohexylamine (0.99 g, 0.01 mol) was dissolved in anhydrous THF under nitrogen and maintained at −78
• C. 2-Bromoacetic acid (1.39 g, 0.01 mol) was slowly added and heated to reach room temperature for 2 h. White powder was filtered off and dried (1.51 g, 96%).
1 H NMR (400 MHz, D 2 O) δ 3.72 (s, 2H), 3.02-2.98 (m, 1H), 1.84 (s, 2H), 1.77-1.75 (s, 2H), 1.53-1.49 (d, J = 12.6 Hz, 1H), 1.25-1.02 (m, 5H).
